Gilead Sciences to Showcase New Findings on HIV, COVID-19, and Viral Hepatitis at IDWeek 2024, Highlighting Advances in Antiviral Research
Gilead Sciences, Inc. announced the upcoming presentation of new findings from its antiviral research and development programs at IDWeek 2024, taking place from October 16-19. The data from 31… read more.
